window._izq.push ([“userProfile”, {“add”: {
“Category”: “News”

# dailymotion-pip-small-viewport {
above: 125px! important;
# dailymotion-pip-large-viewport {
left: 0px! important;
right: auto! important;
below: 140px! important;
} (Function (a, c, s, u) {‘Insticator’in a || (a.Insticator = {ad: {loadAd: function (b) { (b)}, q: []}, helper: {}, embed: {}, version: “4.0”, q: [], load: function (t, o) {Insticator.q.push ({t: t, o: o}) }}); var b = c.createElement (s); b.src = u; b.async =! 0; var d = c.getElementsByTagName (s) [0]; d.parentNode.insertBefore (b, d) }) (Window, Document, ‘Script’, ‘//’)
@media (max-width: 767px) {
.wp-pagenavi {justify-content: normal! important;}

# ctcg_frame_65349_0 {display: none;}
#mc_embed_signup .mc-field-group select {padding: 14px 4px! important;}
.mc-field-group.input-group strong {margin-top: 8px;}
.article-header .share-count .share-it {display: none! important;}
.share.counter {display: none;}
.a2a_dd .a2a_count {display: none! important;}
.article-header .share-count .a2a_dd {justify-content: space-around! important;}
! function (c, h, i, m, p) {m = c.createElement (h), p = c.getElementsByTagName (h) [0], m.async = 1, m.src = i, p.parentNode .insertBefore (m, p)} (document, “script”, “”); (function (w, sd) {var = d.createElement (‘script’); s.src = ‘//’; s.type = ‘text / javascript’; s.async = true; (d.getElementsByTagName ( ‘head’) [0] || d.getElementsByTagName (‘body’) [0]). appendChild (s);}) (window, document);

The Ministry of Health (DOH) said it would be together first conduct a review with local experts before the government buys a supply of Ronapreve medication – a treatment for patients with coronavirus disease (COVID-19).

The DOH made the statement after the Food and Drug Administration ( FDA) issued an Emergency Authorization (EUA) from the country of Ronapreve.

The department said, “Before the government can procure the drug, it needs a positive recommendation from the Health Technology Assessment Council (HTAC) and the Living CPG (Clinical Practice Guidelines).

The DOH said it would “Reviewed the use of Ronapreve with experts who are continuously updating the Living CPG with regard to its use in the clinical treatment of COVID-19 patients,” it said on Saturday October 9th.

“Also the health technology assessment must be completed before hospitals can place a government order. Ronapreve cannot be sold in the market as the government is the only one authorized to source and distribute it, ”she added.

The FDA approved the EUA for Ronapreve on October 1st and is approved for confirmed mild to moderate COVID-19 patients aged 12 and over – with a minimum weight of 40 kilograms, “who do not need additional oxygen and are at high risk for a progression ”. to severe cases. “